State of melanoma: an historic overview of a field in transition
- PMID: 24880939
- PMCID: PMC4040458
- DOI: 10.1016/j.hoc.2014.02.010
State of melanoma: an historic overview of a field in transition
Abstract
The last 30 years has seen a revolution in melanoma. Fundamental elements of the surgical, adjuvant medical, and systemic therapy for the disease have been significantly altered toward improved management and better outcomes. The intent of this article is to reflect on past efforts and research in melanoma and the current landscape of treatment of melanoma. The authors also hope to capture the excitement currently rippling through the field and the hope for a cure. The intent of treatment of advanced melanoma, which was once considered incurable, has changed from palliative to potentially curative.
Keywords: Adjuvant; Biology; Combination therapy; Immunotherapy; Melanoma; Neoadjuvant; Prognosis; Targeted therapies.
Copyright © 2014 Elsevier Inc. All rights reserved.
References
-
- Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29. - PubMed
-
- Miller AJ, Mihm MC., Jr Melanoma. N Engl J Med. 2006;355:51–65. - PubMed
-
- Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations) National Cancer Institute; Bethesda, MD: 2012. http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site, April 2012.
-
- WHO. Skin cancers. 2013.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
